Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERiANP: Pancreatic Enzyme Replacement Therapy in Acute Necrotizing Pancreatitis
NCT07441824Phase 3Recruiting
- Sponsor
- Asian Institute of Gastroenterology
- Start
- Apr 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 3 trial of pancreatin in pancreatic exocrine insufficiency (EPI), sponsored by Asian Institute of Gastroenterology. Started Apr 2026; status: recruiting.
02
Drugs
pancreatin
03
Conditions
pancreatic exocrine insufficiency (EPI)
Beyond the preview
Go deeper on NCT07441824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07441824.